Diary - News
All news Valneva: 2 licences agreements in Japan
The first license agreement was signed with a global pharmaceutical company, which provides products and services in more than 50 countries throughout the world, and a second license agreement was signed with one of the largest animal vaccine manufacturers in Japan, both to evaluate the potential of EB66® cells to produce new vaccines.
